Navigation Links
Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-Label Drug Marketing
Date:4/27/2010

company.  Once approved, the drug may not be marketed or promoted for off-label uses.  

The FDA originally approved Seroquel in September 1997 for the treatment of manifestations of psychotic disorders.  In September 2000, FDA proposed narrowing the approval for Seroquel to the short term treatment of schizophrenia only.  In January 2004, the FDA approved Seroquel for short term treatment of acute manic episodes associated with bipolar disorder (bipolar mania).  In October 2006, the FDA approved Seroquel for bipolar depression.

The United States alleges that AstraZeneca illegally marketed Seroquel for uses never approved by the FDA.  Specifically, between January 2001 through December 2006, AstraZeneca promoted Seroquel to psychiatrists and other physicians for certain uses that were not approved by the FDA as safe and effective (including aggression, Alzheimer's disease, anger management, anxiety, attention deficit hyperactivity disorder, bipolar maintenance, dementia, depression, mood disorder, post-traumatic stress disorder, and sleeplessness).  These unapproved uses were not medically accepted indications for which the United States and the state Medicaid programs provided coverage for Seroquel.

According to the settlement agreement, AstraZeneca targeted its illegal marketing of the anti-psychotic Seroquel towards doctors who do not typically treat schizophrenia or bipolar disorder, such as physicians who treat the elderly, primary care physicians, pediatric and adolescent physicians, and in long-term care facilities and prisons.

In Marc
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 About 8 million Americans have peripheral ... of fatty plaque in the arteries, according to recent ... and in incidences of diabetes and obesity, the ... Extremity Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... interested residents and fellows will be able to gain ...
(Date:8/27/2014)... LAKE CITY , Aug. 27, 2014 Varian ... will expand its current Salt Lake City ... currently underway outside of Utah to ... over the next 20 years. " ... engineering and technical talent, many of whom can be credited ...
(Date:8/27/2014)... 2014 Decision Resources Group finds that the ... Memphis health system and hospital sector in ... rivals Methodist Le Bonheur Healthcare and Baptist Memorial Health ... patient care. In addition, a national contract recently signed ... plan enrollment in the Memphis ...
Breaking Medicine Technology:LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Memphis-area Health Systems Turn Attention to Clinical Integration 2
... Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals ... http://www.reportlinker.com/p0203105/The-Outlook-for-Pharmaceuticals-in-Northern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory The Northern European ... pharmaceutical market value of over US$26 billion ...
... Diagnostics Incorporated (NYSE: DGX ), the world,s ... that it is scheduled to speak at the Lazard ... City.  The presentation is scheduled for Tuesday, November 15, ... the conference, the company will reaffirm its 2011 outlook ...
Cached Medicine Technology:The Outlook for Pharmaceuticals in Northern Europe 2The Outlook for Pharmaceuticals in Northern Europe 3The Outlook for Pharmaceuticals in Northern Europe 4Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 2Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 3Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference 4
(Date:8/27/2014)... (PRWEB) August 27, 2014 The newest ... PA on Monday, September 8, 2014. This new 15,000 ... that features three primary care practices and walk-in laboratory ... is a very exciting endeavor for Abington Health as ... and CEO, Abington Health. “Establishing a location in Lower ...
(Date:8/27/2014)... 2014 (HealthDay News) -- Overconfident people are better at ... are, and therefore are more likely to get promotions ... The researchers added that these "self-deceived" people are also ... take greater risks. And finally, people who underestimate ... according to the British researchers. Their findings were published ...
(Date:8/27/2014)... Recent growth in health care spending for commercially insured ... medical services, rather than increased use, according to a ... for Health Policy & Clinical Practice, published in the ... Care . , There is increasing concern that consolidation ... prices faced by payers and, ultimately, consumers," said Carrie ...
(Date:8/27/2014)... August 27, 2014 Driven by the ... is expected to grow steadily during the next few ... reach 1.381 billion meters by end-2017. Tightness is an ... are one of the most-used parts in an automobile. ... stood at 995 million meters, up just under 15% ...
(Date:8/27/2014)... and Denver (PRWEB) August 27, 2014 ... , has broken ground on a 79,491 square foot ... Health hospital campus in Germantown, an unincorporated municipality located ... the third most populous place in Maryland, after Baltimore ... Holy Cross Germantown Hospital campus is one of three ...
Breaking Medicine News(10 mins):Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Tracking spending among the commercially insured 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 2Health News:Automobile Weatherstrip Sector in China Analysed in New SinoMarketInsight Research Study Published at MarketPublishers.com 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4
... With the cost of,medical care skyrocketing, a ... Health,Solutions finds that better coordination of in-home ... care and drastically reduce,cost., The Deloitte ... Home,",( http://www.deloitte.com/us/connectedcareathome ) promotes self-care and an,electronically ...
... March 8, 2008 Do you remember the seventh song ... yesterday? Most of us dont, thanks to a normal forgetting ... from our brains. Researchers at the Buck Institute now believe ... (AD) and that this effect is key to the profound ...
... Health and Financial ... Pharmaceutical Companies, NEW YORK and LONDON, March 12 ... and causing an,estimated 125,000 deaths per year in the United ... Eularis has,responded to this problem with a new report, available ...
... with dangerous germ, , , WEDNESDAY, March 12 (HealthDay News) -- ... their pets, but one thing you probably never thought you ... , However, according to a letter in the March 13 ... a German family appears to have done just that. Doctors ...
... Protein Corporation,(NYSE: OME ), the nation,s leading producer ... reported net income of $12.1 million,($0.72 a share) for ... income of $4.6 million ($0.19 a share) for the ... For the year ended December 31, 2007, the ...
... and SEATTLE, March 12 DocuSys, Inc., ... medication,management system provider, today announced that Harborview ... I adult and pediatric trauma center,serving a ... anesthesia,solutions, which will automate the documentation of ...
Cached Medicine News:Health News:Deloitte's 'Connected Care' Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions 2Health News:Deloitte's 'Connected Care' Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions 3Health News:Paradoxical Alzheimer's finding may shed new light on memory loss 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 2Health News:Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 3Health News:Woman and Cat Shared 'Super Bug' 2Health News:Woman and Cat Shared 'Super Bug' 3Health News:Omega Protein Reports 2007 Results 2Health News:Omega Protein Reports 2007 Results 3Health News:Omega Protein Reports 2007 Results 4Health News:Omega Protein Reports 2007 Results 5Health News:Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 2Health News:Harborview Medical Center Implements Latest Release of the DocuSys Solution to Improve Anesthesia Medication Safety and Documentation 3
The TS100-F trinocular model comes with a photo port that accepts Nikon's FX-III series photomicrographic systems, CCTV camera, or digital camera....
... TS100 is an innovative and ... high quality tool complements any ... increased stability - Nikon has ... resistant design that greatly reduces ...
Surgical drill bits, twist drills, HSS. Available in various sizes....
... These revised charts incorporate the slight change ... the 10 Sloan letters derived from the ... eyes during the ETDRS study. The original ... examination of 234 eyes. In addition to ...
Medicine Products: